Inspire Biotherapeutics launches to target lung diseases through gene therapy
Inspire Biotherapeutics Inc., an emerging Canadian biotech company with a mission to create gene therapies…
As one of the biggest success stories of the 21st century, gene therapy is providing hope for treating diseases that once seemed incurable. Any genetic mutation causing disease could theoretically be fixed by inserting a new copy of the faulty gene. This means that gene therapy has the potential to treat some previously incurable conditions with a single dose.
By 2025, the FDA expects to approve between 10 and 20 gene therapies each year, and we are already seeing an increase in the number of approvals today. However, the field continues to face a number of obstacles ranging from safety concerns to manufacturing shortages. Read on to get the latest in the gene therapy field.
Gene Therapy Industry Report 2021
In this report, we take a closer look at the growing gene therapy market, current development and manufacturing challenges, and the exciting future ahead for this industry.
Go to ReportInspire Biotherapeutics Inc., an emerging Canadian biotech company with a mission to create gene therapies…
Nanite Inc. has announced an investment from the Cystic Fibrosis Foundation of up to $2…
Marlin Frechette is the chief quality and compliance officer at FUJIFILM Irvine Scientific. But she…
Two of the interviews on the podcast today are related to Bio-Europe Spring. There are…
Hemophilia B, a rare disease that affects more than 230,000 people worldwide is caused by…
Porton Advanced Solutions Ltd. and DanausGT Biotechnology Co., Ltd. have announced a strategic collaboration in…
Lipid nanoparticles have been used to encapsulate CRISPR-Cas9 and deliver it to cells in mice,…
The European Commission has approved the first gene therapy for the treatment of hemophilia B…
By Sander Slootweg, managing partner, Forbion More than 300 million people around the globe are…
Novotech, an Asia Pacific biotech CRO, has published a new global report on phase 1…
Rocket Pharmaceuticals, Inc says the U.S. Food and Drug Administration (FDA) has granted regenerative medicine…
The Cell and Gene Therapy Catapult (CGT Catapult), an independent U.K. innovation and technology organization…